Login to Your Account

A $1B incentive could help antibiotic R&D investment, prevent resistance: EU study

By Nuala Moran
Staff Writer

Wednesday, January 24, 2018

LONDON – A €9.4 million (US$11.5 million) EU study investigating ways to invigorate antibiotic development recommends there should be a market entry award of $1 billion for companies that succeed in getting a novel product to market.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription